Abstract
Background: Advances in the medicinal nanotechnology have given upward thrust to multifunctional efficient nanocarriers that can be engineered with tunable physico-chemical traits to deliver one or extra healing agent(s) appropriately and selectively to the most cancers cells, focusing on intracellular organellespecific drug delivery.
Objective: Large pores of mesoporous silica nanoparticles allow the other particles to be filled with a drug through endocytosis. These emerge as highly attractive class of drug and gene delivery vectors. Gold nanoparticles
can also pack different sizes and several ligands, in order to gain function of targeting tumor cells.
Conclusion: In the present review, we compile the recent advances in mesoporous silica and gold nanoparticles as carriers of drugs and genes to tumors by passive and active approaches with descriptive examples. In addition, market status of mesoporous silica and gold based nanodrugs has been discussed. Finally, the efforts are made to discuss the current challenges and future prospectives.
Keywords: Mesoporous silica and gold based nanovectors in anticancer drug delivery, mechanisms of action, recent advances, current challenges, future prospective, tumors.
Current Organic Chemistry
Title:Recent Advances in Mesoporous Silica and Gold Based Nanovectors in Anticancer Drug Delivery System
Volume: 21 Issue: 23
Author(s): Imran Ali, Sofi Danish Mukhtar, Mohammad Nadeem Lone, Heyam Saad Ali and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Mesoporous silica and gold based nanovectors in anticancer drug delivery, mechanisms of action, recent advances, current challenges, future prospective, tumors.
Abstract: Background: Advances in the medicinal nanotechnology have given upward thrust to multifunctional efficient nanocarriers that can be engineered with tunable physico-chemical traits to deliver one or extra healing agent(s) appropriately and selectively to the most cancers cells, focusing on intracellular organellespecific drug delivery.
Objective: Large pores of mesoporous silica nanoparticles allow the other particles to be filled with a drug through endocytosis. These emerge as highly attractive class of drug and gene delivery vectors. Gold nanoparticles
can also pack different sizes and several ligands, in order to gain function of targeting tumor cells.
Conclusion: In the present review, we compile the recent advances in mesoporous silica and gold nanoparticles as carriers of drugs and genes to tumors by passive and active approaches with descriptive examples. In addition, market status of mesoporous silica and gold based nanodrugs has been discussed. Finally, the efforts are made to discuss the current challenges and future prospectives.
Export Options
About this article
Cite this article as:
Ali Imran, Mukhtar Danish Sofi, Lone Nadeem Mohammad, Ali Saad Heyam and Aboul-Enein Y. Hassan , Recent Advances in Mesoporous Silica and Gold Based Nanovectors in Anticancer Drug Delivery System, Current Organic Chemistry 2017; 21 (23) . https://dx.doi.org/10.2174/1385272820666161025161853
DOI https://dx.doi.org/10.2174/1385272820666161025161853 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Radionuclide Therapy of Cancer with Radiolabeled Antibodies
Anti-Cancer Agents in Medicinal Chemistry From Protein to Peptides: a Spectrum of Non-Hydrolytic Functions of Acetylcholinesterase
Protein & Peptide Letters Protein Secretome Analysis of Evolving and Responding Tumor Ecosystems
Current Proteomics The Urokinase Receptor Interactome
Current Pharmaceutical Design Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment
Current Topics in Medicinal Chemistry DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Copper Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Effects of Vitamin A Deficiency and Opioids on Parvalbumin + Interneurons in the Hippocampus of the HIV-1 Transgenic Rat
Current HIV Research Molecular Targeted Approaches to Cancer Therapy and Prevention Using Chalcones
Current Cancer Drug Targets A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
Current Medicinal Chemistry Molecular Mechanism Aspect of ER Stress in Alzheimer's Disease: Current Approaches and Future Strategies
Current Drug Targets Photo- and Sono-Dynamic Therapy: A Review of Mechanisms and Considerations for Pharmacological Agents Used in Therapy Incorporating Light and Sound
Current Pharmaceutical Design Protein Pool Maintenance During Oxidative Stress
Current Pharmaceutical Design Regulation of Radiation-Induced Apoptosis by Early Growth Response-1 Gene in Solid Tumors
Current Cancer Drug Targets Subject Index To Volune 2
Current Cancer Therapy Reviews Role of NF-κB and NF-κB-regulated Gene Products in Chemoresistance and Radioresistance
Current Cancer Therapy Reviews Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia
Recent Patents on Anti-Cancer Drug Discovery Therapeutic microRNA Delivery Strategies with Special Emphasis on Cancer Therapy and Tumorigenesis: Current Trends and Future Challenges
Current Drug Metabolism Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses
Current Pharmaceutical Biotechnology Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy
Current Drug Targets - Inflammation & Allergy